IN8BIO INC. - COMMON
0.2550
07-十月-24 15:59:48
15 分钟延时
股票
-0.0083
-3.15%
今日范围
0.2402 - 0.2760
ISIN
N/A
来源
NASDAQ
-
IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
04 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
11 12月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
11 12月 2023 09:00:47 条件 Nasdaq GlobeNewswire
-
IN8bio Appoints Dr. Corinne Epperly to Board of Directors
07 12月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
05 12月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
20 11月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
09 11月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
06 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
03 11月 2023 12:00:00 条件 Nasdaq GlobeNewswire
-
02 11月 2023 09:17:21 条件 Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Truist Securities BioPharma Symposium
01 11月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
IN8bio Announces Presentations at the Society for Immunology of Cancer (SITC) 38th Annual Meeting
29 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
26 9月 2023 08:00:01 条件 Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
20 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
IN8bio Strengthens Intellectual Property Portfolio with Newly Granted Global Patents
19 9月 2023 08:03:33 条件 Nasdaq GlobeNewswire
-
IN8bio to Participate at the H.C. Wainwright 25th Annual Global Investment Conference
06 9月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
IN8bio to Present at the H.C. Wainwright Immune Cell Engager Virtual Conference
15 8月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
IN8bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update
10 8月 2023 16:15:37 条件 Nasdaq GlobeNewswire